BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20131183)

  • 21. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
    Elmas E; Brueckmann M; Lang S; Kälsch T; Haghi D; Sueselbeck T; Dempfle CE; Borggrefe M
    Int J Cardiol; 2008 Aug; 128(2):244-9. PubMed ID: 17673312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic and prognostic value of N-terminal pro B-type natriuretic peptide (NT-proBNP) in patients with chronic aortic regurgitation.
    Weber M; Hausen M; Arnold R; Moellmann H; Nef H; Elsaesser A; Mitrovic V; Hamm C
    Int J Cardiol; 2008 Jul; 127(3):321-7. PubMed ID: 18055041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left atrial remodelling in hypertrophic cardiomyopathy: relation with exercise capacity and biochemical markers of tissue strain and remodelling.
    Saura D; Marín F; Climent V; González J; Roldán V; Hernández-Romero D; Oliva MJ; Sabater M; de la Morena G; Lip GY; Valdés M
    Int J Clin Pract; 2009 Oct; 63(10):1465-71. PubMed ID: 19769703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of exercise capacity with cardiopulmonary exercise test and B-type natriuretic peptide in adults with congenital heart disease.
    Trojnarska O; Gwizdała A; Katarzyński S; Katarzyńska A; Szyszka A; Lanocha M; Grajek S; Kramer L
    Cardiol J; 2009; 16(2):133-41. PubMed ID: 19387960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure.
    Rothenburger M; Wichter T; Schmid C; Stypmann J; Tjan TD; Berendes E; Etz C; Pioux A; Löher A; Wenzelburger F; Drees G; Hoffmeier A; Breithardt G; Scheld HH
    J Heart Lung Transplant; 2004 Oct; 23(10):1189-97. PubMed ID: 15477114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NT-proBNP changes, oxidative stress, and energy status of hypertrophic myocardium following ischemia/reperfusion injury.
    Scolletta S; Carlucci F; Biagioli B; Marchetti L; Maccherini M; Carlucci G; Rosi F; Salvi M; Tabucchi A
    Biomed Pharmacother; 2007; 61(2-3):160-6. PubMed ID: 17350221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.
    Vanderheyden M; Bartunek ; Claeys G; Manoharan G; Beckers JF; Ide L
    Clin Biochem; 2006 Jun; 39(6):640-5. PubMed ID: 16516185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of natriuretic peptides in patients with chronic complex (mixed or multiple) heart valve disease.
    Bissessor N; Shanahan L; Wee YS; Stewart R; Lowe B; Kerr A; Zeng I; Jayasinghe R; White H
    Congest Heart Fail; 2010; 16(2):50-4. PubMed ID: 20412468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ventricular reverse remodeling early after mitral valve repair for severe chronic mitral regurgitation with atrial fibrillation.
    Song BG; On YK; Jeon ES; Park JH; Choi JO; Lee SC; Park SW; Kim JS; Park PW
    Cardiology; 2009; 114(2):132-41. PubMed ID: 19521078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Independent value of echocardiography and N-terminal pro-natriuretic Peptide for the prediction of major outcomes in patients with suspected heart failure.
    Lim TK; Hayat SA; Gaze D; Celik E; Collinson P; Senior R
    Am J Cardiol; 2007 Sep; 100(5):870-5. PubMed ID: 17719336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Change of N-terminal pro-brain natriuretic peptide and big endothelin in patients undergoing coronary artery bypass grafting].
    Lu YF; Qi HW; Tang CZ; Wu MY; Wang Y; Zhao FH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Nov; 19(11):667-70. PubMed ID: 17996134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperthyroidism may affect serum N-terminal pro-B-type natriuretic peptide levels independently of cardiac dysfunction.
    Arikan S; Tuzcu A; Gokalp D; Bahceci M; Danis R
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):202-7. PubMed ID: 17547691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NT-proBNP in monitoring treatment of patients with congestive heart failure.
    Al-Meslmani BM; Fahoum SK; Shamia MG
    Clin Lab; 2007; 53(1-2):35-9. PubMed ID: 17323823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes of serum N-terminal pro-brain natriuretic peptide levels in patients with cardiovascular diseases and its clinical significance].
    Yang CL; Qiu YR; Zhou F; Feng PF
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):866-9. PubMed ID: 18504223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit.
    Forfia PR; Watkins SP; Rame JE; Stewart KJ; Shapiro EP
    J Am Coll Cardiol; 2005 May; 45(10):1667-71. PubMed ID: 15893185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements.
    Tschöpe C; Kasner M; Westermann D; Gaub R; Poller WC; Schultheiss HP
    Eur Heart J; 2005 Nov; 26(21):2277-84. PubMed ID: 16014646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke.
    Iltumur K; Yavavli A; Apak I; Ariturk Z; Toprak N
    Am Heart J; 2006 May; 151(5):1115-22. PubMed ID: 16644347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No firm association between N-terminal pro-brain natriuretic peptide and percentage of pulmonary vascular obstruction in patients with acute pulmonary embolism.
    Agterof MJ; Schutgens RE; Verzijlbergen JF; van Buul MM; Tromp EA; Eijkemans MJ; van der Griend R; Biesma DH
    Thromb Res; 2011 Jun; 127(6):547-50. PubMed ID: 21421260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population.
    Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
    Eur Heart J; 2007 Jun; 28(11):1374-81. PubMed ID: 17242007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
    J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.